Bono P - Search Results

1

Adjuvant Capecitabine for Early Breast Cancer: 15-Year Overall Survival Results From a Randomized Trial.

Joensuu H, Kellokumpu-Lehtinen PL, Huovinen R, Jukkola A, Tanner M, Ahlgren J, Auvinen P, Lahdenperä O, Villman K, Nyandoto P, Nilsson G, Poikonen-Saksela P, Kataja V, Bono P, Junnila J, Lindman H. Joensuu H, et al. Among authors: bono p. J Clin Oncol. 2022 Apr 1;40(10):1051-1058. doi: 10.1200/JCO.21.02054. Epub 2022 Jan 12. J Clin Oncol. 2022. PMID: 35020465 Free PMC article. Clinical Trial.

2

Elevated serum endostatin is associated with poor outcome in patients with non-Hodgkin lymphoma.

Bono P, Teerenhovi L, Joensuu H. Bono P, et al. Cancer. 2003 Jun 1;97(11):2767-75. doi: 10.1002/cncr.11399. Cancer. 2003. PMID: 12767089 Free article.

3

Interferon alfa-2b three times daily and thalidomide in the treatment of metastatic renal cell carcinoma.

Hernberg M, Virkkunen P, Bono P, Ahtinen H, Mäenpää H, joensuu H. Hernberg M, et al. Among authors: bono p. J Clin Oncol. 2003 Oct 15;21(20):3770-6. doi: 10.1200/JCO.2003.01.536. J Clin Oncol. 2003. PMID: 14551295 Clinical Trial.

4

[Anti-angiogenic treatment is effective for treating metastatic colorectal cancers].

Bono P, Joensuu H. Bono P, et al. Duodecim. 2004;120(3):261-2. Duodecim. 2004. PMID: 15061003 Finnish. No abstract available.

5

Serum KIT and KIT ligand levels in patients with gastrointestinal stromal tumors treated with imatinib.

Bono P, Krause A, von Mehren M, Heinrich MC, Blanke CD, Dimitrijevic S, Demetri GD, Joensuu H. Bono P, et al. Blood. 2004 Apr 15;103(8):2929-35. doi: 10.1182/blood-2003-10-3443. Epub 2004 Jan 8. Blood. 2004. PMID: 15070666 Free article. Clinical Trial.

6

High LYVE-1-positive lymphatic vessel numbers are associated with poor outcome in breast cancer.

Bono P, Wasenius VM, Heikkilä P, Lundin J, Jackson DG, Joensuu H. Bono P, et al. Clin Cancer Res. 2004 Nov 1;10(21):7144-9. doi: 10.1158/1078-0432.CCR-03-0826. Clin Cancer Res. 2004. PMID: 15534085

7

Cytoplasmic HuR expression is a prognostic factor in invasive ductal breast carcinoma.

Heinonen M, Bono P, Narko K, Chang SH, Lundin J, Joensuu H, Furneaux H, Hla T, Haglund C, Ristimäki A. Heinonen M, et al. Among authors: bono p. Cancer Res. 2005 Mar 15;65(6):2157-61. doi: 10.1158/0008-5472.CAN-04-3765. Cancer Res. 2005. PMID: 15781626

8

Lymphatic vessel density in vocal cord carcinomas assessed with LYVE-1 receptor expression.

Koskinen WJ, Bono P, Leivo I, Vaheri A, Aaltonen LM, Joensuu H. Koskinen WJ, et al. Among authors: bono p. Radiother Oncol. 2005 Nov;77(2):172-5. doi: 10.1016/j.radonc.2005.09.013. Epub 2005 Oct 17. Radiother Oncol. 2005. PMID: 16229916

9

Adjuvant docetaxel or vinorelbine with or without trastuzumab for breast cancer.

Joensuu H, Kellokumpu-Lehtinen PL, Bono P, Alanko T, Kataja V, Asola R, Utriainen T, Kokko R, Hemminki A, Tarkkanen M, Turpeenniemi-Hujanen T, Jyrkkiö S, Flander M, Helle L, Ingalsuo S, Johansson K, Jääskeläinen AS, Pajunen M, Rauhala M, Kaleva-Kerola J, Salminen T, Leinonen M, Elomaa I, Isola J; FinHer Study Investigators. Joensuu H, et al. Among authors: bono p. N Engl J Med. 2006 Feb 23;354(8):809-20. doi: 10.1056/NEJMoa053028. N Engl J Med. 2006. PMID: 16495393 Free article. Clinical Trial.

10

Clinical and molecular studies of the effect of imatinib on advanced aggressive fibromatosis (desmoid tumor).

Heinrich MC, McArthur GA, Demetri GD, Joensuu H, Bono P, Herrmann R, Hirte H, Cresta S, Koslin DB, Corless CL, Dirnhofer S, van Oosterom AT, Nikolova Z, Dimitrijevic S, Fletcher JA. Heinrich MC, et al. Among authors: bono p. J Clin Oncol. 2006 Mar 1;24(7):1195-203. doi: 10.1200/JCO.2005.04.0717. J Clin Oncol. 2006. PMID: 16505440

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

178 results

Search Page